Get started
Author

Kay Brinkmann

Observed names: Brinkmann, Kay, K. Brinkmann, Kay Brinkman
OpenAlex ID: A5087929718
Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma
2017 · A.K. Krug, D. Enderle, et al. · Annals of Oncology · 277
Exosome Targeting of Tumor Antigens Expressed by Cancer Vaccines Can Improve Antigen Immunogenicity and Therapeutic Efficacy
2011 · Ryan B. Rountree, Stefanie J. Mandl, et al. · Cancer Research · 163
PDF
Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAF V600E mutation
2019 · Susana García-Silva, Alberto Benito-Martín, et al. · The Journal of Experimental Medicine · 135
Vector systems for heterologous expression of proteins in Saccharomyces cerevisiae
2002 · Martin Funk, Rainer Niedenthal, et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 59
Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma
2018 · A.K. Krug, D. Enderle, et al. · Annals of Oncology · 55
The Vaccinia Virus O1 Protein Is Required for Sustained Activation of Extracellular Signal-Regulated Kinase 1/2 and Promotes Viral Virulence
2011 · Marc Schweneker, Susanne Lukassen, et al. · Journal of Virology · 54
PDF
Immediate-Early Expression of a Recombinant Antigen by Modified Vaccinia Virus Ankara Breaks the Immunodominance of Strong Vector-Specific B8R Antigen in Acute and Memory CD8 T-Cell Responses
2010 · Karen Baur, Kay Brinkmann, et al. · Journal of Virology · 53
Extracellular vesicles from plasma have higher tumour RNA fraction than platelets
2020 · Kay Brinkman, Lisa Meyer, et al. · Journal of Extracellular Vesicles · 45
PDF
A Novel Naturally Occurring Tandem Promoter in Modified Vaccinia Virus Ankara Drives Very Early Gene Expression and Potent Immune Responses
2013 · Sonia T. Wennier, Kay Brinkmann, et al. · PLoS ONE · 29
PDF
Recombinant Modified Vaccinia Virus Ankara Generating Excess Early Double-Stranded RNA Transiently Activates Protein Kinase R and Triggers Enhanced Innate Immune Responses
2014 · Michael Wolferstätter, Marc Schweneker, et al. · Journal of Virology · 25
NLRC4 Inflammasome-Driven Immunogenicity of a Recombinant MVA Mucosal Vaccine Encoding Flagellin
2018 · Stephanie L. Sanos, Ronny Kassub, et al. · Frontiers in Immunology · 17
Correction: Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAF V600E mutation
2019 · Susana García-Silva, Alberto Benito-Martín, et al. · The Journal of Experimental Medicine · 15
PDF
Abstract 545: Plasma-based diagnostics for detection of EML4-ALK fusion transcripts in NSCLC patients
2015 · Kay Brinkmann, Daniel Enderle, et al. · Cancer Research · 15
Abstract B136: Plasma EGFR mutation detection using a combined exosomal RNA and circulating tumor DNA approach in patients with acquired resistance to first-generation EGFR-TKIs
2015 · Anne K. Krug, Chris Karlovich, et al. · Molecular Cancer Therapeutics · 14
Genetic Adjuvantation of Recombinant MVA with CD40L Potentiates CD8 T Cell Mediated Immunity
2013 · Henning Lauterbach, Juliane Pätzold, et al. · Frontiers in Immunology · 14
PDF
Exosome liquid biopsies of NSCLC patients for longitudinal monitoring of ALK fusions and resistance mutations.
2018 · Kay Brinkmann, Daniel Enderle, et al. · Journal of Clinical Oncology · 11
Plasma-based monitoring of BRAF mutations during therapy for malignant melanoma (MM) using combined exosomal RNA and cell-free DNA analysis.
2015 · Ryan J. Sullivan, Vincent J. O'Neill, et al. · Journal of Clinical Oncology · 8
CD 70 encoded by modified vaccinia virus Ankara enhances CD 8 T‐cell‐dependent protective immunity in MHC class II ‐deficient mice
2017 · Barbara Bathke, Juliane Pätzold, et al. · Immunology · 5
PDF
Detection of EGFR activating and T790M resistance mutations in plasma of lung cancer patients using combined exosomal RNA and cfDNA capture.
2015 · Kay Brinkmann, Daniel Enderle, et al. · Journal of Clinical Oncology · 2
454 Monitoring therapy response and resistance mutations in circulating RNA and DNA of plasma from patients with malignant melanoma
2014 · D. Enderle, K. Brinkmann, et al. · European Journal of Cancer · 2
313 Development of a one-step isolation platform for exosomal RNA and circulating cell-free DNA from cancer plasma samples
2014 · D. Enderle, K. Brinkmann, et al. · European Journal of Cancer · 1
Supplementary Figure 1 from Exosome Targeting of Tumor Antigens Expressed by Cancer Vaccines Can Improve Antigen Immunogenicity and Therapeutic Efficacy
2023 · Ryan B. Rountree, Stefanie J. Mandl, et al.
Supplementary Figure 2 from Exosome Targeting of Tumor Antigens Expressed by Cancer Vaccines Can Improve Antigen Immunogenicity and Therapeutic Efficacy
2023 · Ryan B. Rountree, Stefanie J. Mandl, et al.
Supplementary Figure 2 from Exosome Targeting of Tumor Antigens Expressed by Cancer Vaccines Can Improve Antigen Immunogenicity and Therapeutic Efficacy
2023 · Ryan B. Rountree, Stefanie J. Mandl, et al.
PDF
Data from Exosome Targeting of Tumor Antigens Expressed by Cancer Vaccines Can Improve Antigen Immunogenicity and Therapeutic Efficacy
2023 · Ryan B. Rountree, Stefanie J. Mandl, et al.
Works count: 30
Citation count: 999
H-index: 14
I10-index: 16
Year
Topic
Type